Laxmi Dental: IPO Proceeds Utilization in Line with Objects for Q3 FY26
Laxmi Dental's Q3 FY26 Monitoring Agency Report shows IPO proceeds utilization aligns with stated objects. Total IPO size was ₹698.058 crore. During Q3 FY26, ₹73.814 crore was utilized, with ₹61.198 crore remaining unutilized. Unutilized funds are largely invested in fixed deposits.
This is a routine regulatory filing providing an update on IPO proceeds utilization. It does not contain new financial performance data or significant corporate actions that would materially impact the company's valuation or operations.
The report indicates no material deviation in the utilization of IPO proceeds, which is a neutral development. It provides a factual update on fund utilization and progress against the objects of the issue.
Laxmi Dental Limited has submitted its Monitoring Agency Report for the quarter ended December 31, 2025. The report, issued by ICRA Limited, indicates no material deviation in the utilization of IPO proceeds from the objects stated in the offer document.
The company's IPO, which opened on January 13, 2025, and closed on January 15, 2025, had an issue size of ₹698.058 crore. The net proceeds as per the prospectus were ₹128.170 crore. For the quarter ended December 31, 2025 (Q3 FY26), the gross proceeds monitored were ₹138.000 crore.
Key utilization details for the quarter include ₹22.984 crore for repayment of borrowings, ₹4.600 crore for investment in subsidiaries for repayment of borrowings, ₹4.598 crore towards funding capital expenditure for new machinery, and ₹31.936 crore for general corporate purposes. A total of ₹73.814 crore was utilized during the quarter, with an unutilized amount of ₹61.198 crore as of December 31, 2025.
The report also details the deployment of unutilized proceeds, primarily in fixed deposits with ICICI Bank, amounting to ₹62.525 crore, which generated earnings of ₹2.787 crore during the quarter. The maturities for these fixed deposits range from January 2026 to December 2027.
Regarding delays in implementation, the repayment of borrowings and investment in subsidiaries for repayment were on schedule. Funding for capital expenditure and investment in Bizdent Devices Private Limited for new machinery experienced a delay, with completion expected in Q1FY2026 and Q3FY2026 respectively. General corporate purposes were completed in Q3FY2026.
What to do with a filing like this
Laxmi Dental Limited filed this with the NSE as a statutory disclosure, categorised under other regulatory filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Laxmi Dental Limited. Read the original for the full detail.